Norris Perne & French LLP/Mi / ABT
Norris Perne & French LLP/Mi’s Abbott Laboratories Position
Does Norris Perne & French LLP/Mi own Abbott Laboratories (ABT)? Yes — 168.1K shares worth $17M (+1.15% of its 13F portfolio) as of Q1 2026, down from 209.5K shares the prior filed quarter.
Position Value
$17M
Q1 2026
Shares
168.1K
% of Portfolio
+1.15%
Quarters Held
30
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 168.1K | $17M | +1.15% |
| Q4 2025 | 209.5K | $26M | +1.73% |
| Q3 2025 | 215.1K | $29M | +2.00% |
| Q2 2025 | 220.5K | $30M | +2.09% |
| Q1 2025 | 223.2K | $30M | +2.22% |
| Q4 2024 | 226.3K | $26M | +1.85% |
| Q3 2024 | 226.2K | $26M | +1.77% |
| Q2 2024 | 228.8K | $24M | +1.72% |
| Q1 2024 | 144.3K | $16M | +1.18% |
| Q4 2023 | 142.6K | $16M | +1.21% |
| Q3 2023 | 140.2K | $14M | +1.19% |
| Q2 2023 | 137.6K | $15M | +1.26% |
| Q1 2023 | 136.0K | $14M | +1.26% |
| Q4 2022 | 134.9K | $15M | +1.46% |
| Q3 2022 | 138.2K | $13M | +1.39% |
| Q2 2022 | 136.7K | $15M | +1.43% |
| Q1 2022 | 134.6K | $16M | +1.29% |
| Q4 2021 | 133.2K | $19M | +1.45% |
| Q3 2021 | 131.7K | $16M | +1.34% |
| Q2 2021 | 128.7K | $15M | +1.29% |
| Q1 2021 | 125.2K | $15M | +1.39% |
| Q4 2020 | 108.7K | $12M | +1.12% |
| Q3 2020 | 106.3K | $12M | +1.26% |
| Q2 2020 | 107.2K | $10M | +1.19% |
| Q1 2020 | 105.9K | $8M | +1.25% |
| Q4 2019 | 107.2K | $9M | +1.11% |
| Q3 2019 | 229.9K | $19M | +2.40% |
| Q2 2019 | 230.9K | $19M | +2.45% |
| Q1 2019 | 231.1K | $18M | +2.43% |
| Q4 2018 | 283.3K | $20M | +3.20% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Norris Perne & French LLP/Mi’s full portfolio or all institutional holders of ABT.